Interestingly, plasma levels of ET-1 and BNP have been significantly correlated in patients with PAH, generating the hypothesis that increased levels of ET-1 may result from systemic neuro-hormonal activation [21]. Here, EDN1 is linked to pulmonary arterial hypertension.